Illumina

Illumina Hits a Speed Bump in the 2nd Quarter
Illumina Hits a Speed Bump in the 2nd Quarter
Motley Fool
Illumina
earnings
Flag link:
Illumina plunges after slashing revenue expectations
Illumina plunges after slashing revenue expectations
CNBC
Illumina
earnings
Flag link:
Element Biosciences Lands $15M to Develop New Genetic Analysis Tools
Element Biosciences Lands $15M to Develop New Genetic Analysis Tools
Xconomy
DNA sequencing
gene sequencing
Illumina
Element Biosciences
Flag link:
Complete Genomics Files Lawsuit Against Illumina
Complete Genomics Files Lawsuit Against Illumina
Medical Devices and Diagnostics Industry
Illumina
Complete Genomics
patents
diagnostics
gene sequencing
Flag link:
Where Will Illumina Be in 10 Years?
Where Will Illumina Be in 10 Years?
Motley Fool
Illumina
gene sequencing
Flag link:
Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
Motley Fool
Illumina
earnings
Pacific Biosciences
Flag link:
Pump the Brakes on the Illumina and Pacific Biosciences Deal
Pump the Brakes on the Illumina and Pacific Biosciences Deal
Motley Fool
Illumina
Pacific Biosciences
DNA sequencing
M&A
Flag link:
3 Things You Can Expect From Illumina's Q4 Earnings Update
3 Things You Can Expect From Illumina's Q4 Earnings Update
Motley Fool
Illumina
gene sequencing
earnings
Flag link:
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
Flag link:
Where Will Illumina, Inc. Be in 10 Years?
Where Will Illumina, Inc. Be in 10 Years?
Motley Fool
Illumina
genomic sequencing
Flag link:
Illumina taking out Pacific Biosciences for $1.2B
Illumina taking out Pacific Biosciences for $1.2B
BioCentury
Illumina
Pacific Biosciences
M&A
genomics
Flag link:
Here's Why Illumina Stock Has Gained 28.3% in 2018 (So Far)
Here's Why Illumina Stock Has Gained 28.3% in 2018 (So Far)
Motley Fool
Illumina
DNA sequencing
NovaSeq
Flag link:
Here's Why Illumina, Inc. Stock Gained 13.1% in May
Here's Why Illumina, Inc. Stock Gained 13.1% in May
Motley Fool
Illumina
gene sequencing
Edico Genome
M&A
Flag link:
A Need for Speed: Illumina Acquires San Diego’s Edico Genome
A Need for Speed: Illumina Acquires San Diego’s Edico Genome
Xconomy
Illumina
Edico Genome
M&A
Flag link:
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Forbes
Bristol-Myers Squibb
Illumina
DNA sequencing
Opdivo
diagnostics
Flag link:
How biotech firm Illumina smooths out buying for online customers
How biotech firm Illumina smooths out buying for online customers
Digital Commerce 360
Illumina
genomics
e-commerce
Flag link:
5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
Motley Fool
Illumina
JPMHC 2018
NovaSeq
iSeq
Thermofisher
gene sequencing
Flag link:
Illumina Unveils $20,000 Desktop Sequencer Aimed At Sequencing Germs
Illumina Unveils $20,000 Desktop Sequencer Aimed At Sequencing Germs
Forbes
Illumina
DNA sequencing
iSeq
JPMHC 2018
Flag link:
Disruptor Alert: These 5 Companies Are Changing Healthcare
Disruptor Alert: These 5 Companies Are Changing Healthcare
Motley Fool
CRISPR Therapeutics
Editas Medicine
Illumina
IBM
Intellia Therapeutics
gene editing
gene sequencing
artificial intelligence
Flag link:
3 Things to Expect in Illumina's Q3 Earnings Results
3 Things to Expect in Illumina's Q3 Earnings Results
Motley Fool
Illumina
earnings
Flag link:

Pages